Edward Jenner Institute for Vaccine Research: Difference between revisions
CSV import |
CSV import |
||
| Line 29: | Line 29: | ||
{{Medicine-stub}} | {{Medicine-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 11:10, 17 March 2025
Edward Jenner Institute for Vaccine Research is a research institute based in the United Kingdom, dedicated to the development and advancement of vaccines and immunotherapy. Named after Edward Jenner, the pioneer of the smallpox vaccine, the institute is a hub for innovative research and development in the field of vaccinology.
History[edit]
The Edward Jenner Institute for Vaccine Research was established in 1995 as a collaboration between the Medical Research Council, the Institute of Animal Health and the Wellcome Trust. The institute was created with the aim of advancing the understanding of the immune system and developing new vaccines and immunotherapies.
Research[edit]
The institute conducts research in a variety of areas related to vaccines and immunotherapy. This includes the development of new vaccines for diseases such as HIV, malaria, and tuberculosis, as well as research into the immune response to these diseases. The institute also conducts research into the development of cancer vaccines and autoimmune diseases.
Collaborations[edit]
The Edward Jenner Institute for Vaccine Research collaborates with a number of other research institutions and organisations around the world. These collaborations aim to accelerate the development of new vaccines and immunotherapies, and to share knowledge and expertise in the field of vaccinology.
Impact[edit]
The work of the Edward Jenner Institute for Vaccine Research has had a significant impact on the field of vaccinology. The institute's research has contributed to the development of new vaccines and immunotherapies, and has advanced the understanding of the immune system and how it responds to disease.
See also[edit]

